Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Epitome Pharmaceuticals Ltd.

www.epitomepharm.com

Latest From Epitome Pharmaceuticals Ltd.

MediGene licenses Veregen in Taiwan

The German biotech company MediGene has signed another licence and supply agreement for the commercialisation and marketing of Veregen (previously Polyphenon E) ointment for the treatment of genital warts, this time with SynCore Biotechnology in Taiwan.

Venezuela

Marketing deal for MediGene's genital warts treatment follows first European approval

The German biotechnology company MediGene has signed a licence agreement with Solvay Arzneimittel, the German subsidiary of Solvay Pharmaceuticals, for the supply and commercialisation of Veregen (formerly Polyphenon E ointment) for the treatment of genital warts in Germany, Austria and Switzerland.

Switzerland Companies

Yamanouchi Deal Brings MediGene Breathing Space

MediGene's recent licensing deal with Yamanouchi buys the German biotech time, but does little to strengthen its long-term finances. For this, MediGene will likely have to brave the cold waters of the German capital markets. It will be the first biotech to do so since Germany's growth market collapsed in 2001.
BioPharmaceutical Europe

EpiCept Corp.

Pain is mysteriously complex, but EpiCept has a simple approach that thwarts deep pain. By applying topical anesthetics to the surface of the skin in a proprietary patch, EpiCept has been able to relieve migraines and deep pain in the lower back. The company is also targeting surgical pain and neuropathic pain.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Epitome Pharmaceuticals Ltd.
  • Senior Management
  • Paul T Wegener, Pres.
  • Contact Info
  • Epitome Pharmaceuticals Ltd.
    Phone: (902) 492-1814
    5162 Duke St., Ste. 500
    Halifax, B3J 1N7
    Canada
UsernamePublicRestriction

Register